A new clinical trial finds no cardiovascular benefit from high-dose multivitamins, with or without chelation therapy, in patients with diabetes and past myocardial infarction. High-dose oral ...

Healthline’s writers, editors, dietitians, and medical team spend a lot of time evaluating nutritional supplements. In fact, we’ve reviewed and vetted more than 450 supplement brands.

The company, which makes Sensodyne toothpaste, ENO antacids and Centrum multivitamins ... had gained around 20% since its spin-off from GSK (GSK.L), opens new tab in 2022. "The stock has moved ...

Here’s everything you need to know about vitamins for kids, whether your child may need them, and the best products to choose from, as well as a few others that are worth considering.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other pharmaceutical stocks. Almost no other industry goes as far as the phrase "defensive" as the ...

Diet and lifestyle play crucial roles in maintaining hormonal harmony, but vitamins and minerals also support the endocrine system in regulating hormone production and function. In an exclusive ...

The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. A panel of leaders at the PMCPA, pharma’s ...

Canada has announced a deal to secure 500K doses of GSK’s (NYSE:GSK) avian influenza vaccine for humans as the country steps up efforts to protect at-risk individuals and bolster its federal ...

The shares of GlaxoSmithKline Pharmaceuticals Ltd (GSK Pharma) jumped over 15 percent to trade at Rs 2,684 apiece on February 18, extending gains for the second straight session after releasing ...

GSK's revenue and EPS exceeded my expectations and those of analysts, thanks to the strong performance of its oncology and HIV franchises. So, Ojjaara/Omjjara sales amounted to $150 million in the ...

The Food and Drug Administration on Friday gave a green light to a new meningococcal vaccine from GSK. Dubbed Penmenvy, the “5-in-1” shot is approved for people aged 10 through 25 years old and ...